Skip to main content
Article thumbnail
Location of Repository

a. Invasive Bladder Cancer (2D) b. In situ Breast Cancer (2D)

By C. Stage A, B Colorectal Cancer (d and D. Lymphoma (d


2. We suggest that screening for malignancy prior to transplantation be conducted in accordance with usual age and sex appropriate cancer screening policies for the general population. (Ungraded) [Comment: This could be a recommendation if it is felt to be an obvious clinical decision i.e. there would be no reason not to do it from a risk/benefit even though it is ungraded.] 3. We suggest that consideration be given to the following minimum waiting periods from successful treatment of malignancy to transplantation. Nil

Topics: Not Recommended
Year: 2011
OAI identifier: oai:CiteSeerX.psu:
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.